Abstract:Background: Cells of the immune system can inhibit tumor growth and progression; however, immune cells can also promote tumor cell growth, survival, and angiogenesis as a result of the immunosuppressive microenvironments. In the last decade, a growing number of new therapeutic strategies focused on reversing the immunosuppressive status of tumor microenvironments (TMEs), to reprogram the TME to be normal, and to further activate the antitumor functions of immune cells. Most of the “hot tumors” are encompassed with M2 macrophages promoting tumor growth, and the accumulation of M2 macrophages into tumor islets leads to poor prognosis in a wide variety of tumors. Summary: Therefore, how to uncover more immunosuppressive signals and to reverse the M2 tumor-associated macrophages (TAMs) to M1-type macrophages is essential for reversing the immunosuppressive state. Except for reeducation of TAMs in the cancer immunotherapy, macrophages as central effectors and regulators of the innate immune system have the capacity of phagocytosis and immune modulation in macrophage-based cell therapies. Key Messages: We review the current macrophage-based cell therapies that use genetic engineering to augment macrophage functionalities with antitumor activity for the application of novel genetically engineered immune cell therapeutics. A combination of TAM reeducation and macrophage-based cell strategy may bring us closer to achieving the original goals of curing cancer. In this review, we describe the characteristics, immune status, and tumor immunotherapy strategies of macrophages to provide clues and evidences for future macrophage-based immune cell therapies.

Potential applications of macrophages in cancer immunotherapy

Macrophages as a Potential Immunotherapeutic Target in Solid Cancers

The promising role of tumor-associated macrophages in the treatment of cancer

Harnessing the innate immune system by revolutionizing macrophage-mediated cancer immunotherapy

Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy

Engineering Macrophages for Cancer Immunotherapy and Drug Delivery

New insights into the role of macrophages in cancer immunotherapy

An update to experimental and clinical aspects of tumor-associated macrophages in cancer development: hopes and pitfalls

Macrophages as regulators of tumour immunity and immunotherapy

Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy

Leveraging macrophages for cancer theranostics

Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy

Macrophages as potential targets in gene therapy for cancer treatment

Macrophages as tools and targets in cancer therapy

Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma

Engineering macrophages and their derivatives: A new hope for antitumor therapy

Targeting the macrophage immunocheckpoint: a novel insight into solid tumor immunotherapy

The complex role of macrophages in pancreatic cancer tumor microenvironment: a review on cancer progression and potential therapeutic targets

The portrayal of macrophages as tools and targets: A paradigm shift in cancer management

Macrophage-modulating nanomedicine for cancer immunotherapy

Macrophage: Hidden Criminal in Therapy Resistance.